Anticuerpo especifico anti-s100a4 con actividad antiangiogenica o un fragmento del mismo producido por un hibridoma seleccionado del grupo ecacc 10022401, ecacc 11051801, ecacc 11051802, ecacc 11051803 y ecacc 11051804; lineas celulares que lo producen; composición farmacéutica que la comprende; uso del anticuerpo para tratar enfermedad asociada con inflamación
The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Spanish |
Published |
14.02.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof. |
---|---|
Bibliography: | Application Number: CL20120003538 |